JAZZ PHARMACEUTICALS UK HOLDINGS LIMITED

Company number 13150429

Date	Type	Description	View / Download
18 Apr 2024	AP03	Appointment of Alkesh Patel as a secretary on 3 April 2024	(2 pages)
18 Apr 2024	TM02	Termination of appointment of Aislinn Jane Doody as a secretary on 3 April 2024	(1 page)
05 Mar 2024	CS01	Confirmation statement made on 1 February 2024 with no updates	(3 pages)
23 Jan 2024	MR01	Registration of charge 131504290003, created on 19 January 2024	(131 pages)
16 Jan 2024	PSC05	Change of details for Jazz Pharmaceuticals Plc as a person with significant control on 21 January 2021	(2 pages)
27 Sep 2023	AA	Full accounts made up to 31 December 2022	(25 pages)
26 Jun 2023	CH01	Director's details changed for Mr Luca Giacomo Marchetti on 22 June 2023	(2 pages)
09 Jun 2023	AP01	Appointment of Mr Luca Giacomo Marchetti as a director on 31 May 2023	(2 pages)
28 Mar 2023	TM01	Termination of appointment of Gillian Dines as a director on 13 March 2023	(1 page)
01 Feb 2023	CS01	Confirmation statement made on 1 February 2023 with updates	(4 pages)
16 Jan 2023	AP01	Appointment of Mr David Spackman as a director on 13 January 2023	(2 pages)
13 Jan 2023	AP03	Appointment of Ms Aislinn Jane Doody as a secretary on 13 January 2023	(2 pages)
13 Jan 2023	TM02	Termination of appointment of Iain Stuart Ward as a secretary on 13 January 2023	(1 page)
13 Jan 2023	TM01	Termination of appointment of Adrian Campbell as a director on 1 January 2023	(1 page)
20 Dec 2022	SH19	Statement of capital on 20 December 2022 USD 0.01	(3 pages)
20 Dec 2022	SH20	Statement by Directors	(1 page)
20 Dec 2022	CAP-SS	Solvency Statement dated 16/12/22	(1 page)
20 Dec 2022	RESOLUTIONS	Resolutions RES06 ‐ Resolution of reduction in issued share capital	(1 page)
06 Oct 2022	TM01	Termination of appointment of Christopher Tovey as a director on 29 September 2022	(1 page)
16 Sep 2022	AA	Full accounts made up to 31 December 2021	(24 pages)
04 Feb 2022	CS01	Confirmation statement made on 1 February 2022 with updates	(6 pages)
26 Jan 2022	SH01	Statement of capital following an allotment of shares on 6 May 2021 USD 3,460,456,385.01	(4 pages)
26 Jan 2022	SH01	Statement of capital following an allotment of shares on 5 May 2021 USD 2,754,000,000.01	(4 pages)
26 Jan 2022	SH01	Statement of capital following an allotment of shares on 5 May 2021 USD 3,362,456,385.01	(4 pages)
05 Nov 2021	AP01	Appointment of Rowena Holland as a director on 2 November 2021	(2 pages)